Wockhardt Chairman On Novel Drug For Superbugs, Proposed US Tariffs On Pharma

Wockhardt chairman Habil Khorakiwala discusses commercial plans for novel drugs against multidrug-resistant (MDR) bacteria, impact of proposed US tariffs on pharmaceutical imports from Europe and the way forward for research in India with Citeline's Vibha Ravi

#biotech #pharmaceutical #R&D #Manufacture #Tariffs #TradePolicy

Copyright @ Citeline

Related links
Free to view – https://scrip.citeline.com/SC148668/M...

Subscription required - https://insights.citeline.com/scrip/f...